Antiflammin-2 activates the human formyl-peptide receptor like 1

TheScientificWorldJournal

Volumn 6, Issue , 2006, Pages 1375-1384

  Kamal, Ahmad M ^a   Hayhoe, Richard P G ^a   Paramasivam, Anbalakan ^a   Cooper, Dianne ^a   Flower, Roderick J ^a   Solito, Egle ^b   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

ALX; Annexin 1; Annexin A1; Anti inflammation; Anti inflammatory agents; Anti inflammatory drugs; Antiflammin; Binding; Drug development; Flow chamber; Formyl peptide receptors; FPR; FPRL 1; Inflammation; Lipocortin; Neutrophil; Peptides; PMN; Signal transduction

Indexed keywords

ANTIFLAMMIN 2; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; LIPOCORTIN 1; UNCLASSIFIED DRUG; UTEROGLOBIN;

ARTICLE; CELL INTERACTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NEUTROPHIL; PROTEIN BINDING; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BINDING, COMPETITIVE; CELLS, CULTURED; HUMANS; KIDNEY; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN;

EID: 33750826391     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2006.247     Document Type: Article

References (39)

1. Perretti, M. and Flower, R.J. (2004) Annexin 1 and the biology of the neutrophil. J. Leukoc. Biol. 75, 25-29.
2. Maderna, P., Yona, S., Perretti, M., and Godson, C. (2005) Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac2-26. J. Immunol. 174, 3727-3733.
3. Cuzzocrea, S., Tailor, A., Zingarelli, B., Salzman, A.L., Flower, R.J., Szab¢, C., and Perretti, M. (1997) Lipocortin 1 protects against splanchnic artery occlusion and reperfusion injury by affecting neutrophil migration. J. Immunol. 159, 5089-5097.
4. La, M., Tailor, A., D'Amico, M., Flower, R.J., and Perretti, M. (2001) Analysis of the protection afforded by annexin 1 in ischaemia-reperfusion injury: focus on neutrophil recruitment. Eur. J. Pharmacol. 429, 263-278.
5. Perretti, M., Wheller, S.K., Choudhury, Q., Croxtall, J.D., and Flower, R.J. (1995) Selective inhibition of neutrophil function by a peptide derived from lipocortin 1 N-terminus. Biochem. Pharmacol. 50, 1037-1042.
6. Zouki, C., Ouellet, S., and Filep, J.G. (2000) The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells. FASEB J. 14, 572-580.
7. Cirino, G., Cicala, C., Sorrentino, L., Ciliberto, G., Arpaia, G., Perretti, M., and Flower, R.J. (1993) Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1. Br. J. Pharmacol. 108, 573-574.
8. Perretti, M., Ahluwalia, A., Harris, J.G., Goulding, N.J., and Flower, R.J. (1993) Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse: a qualitative comparison with an anti-CD11b monoclonal antibody. J. Immunol. 151, 4306-4314.
9. Perretti, M. (2003) The annexin 1 receptor(s): is the plot unravelling? Trends Pharmacol. Sci. 24, 574-579.
10. Ernst, S., Lange, C., Wilbers, A., Goebeler, V., Gerke, V., and Rescher, U. (2004) An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. J. Immunol. 172, 7669-7676.
11. Miele, L., Cordella-Miele, E., Facchiano, A., and Mukherjee, A.B. (1988) Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I. Nature 335, 726-730.
12. 2-inhibitory and anti-inflammatory activity. FEBS Lett. 264, 171-175.
13. Camussi, G., Tetta, C., Bussolino, F., and Baglioni, C. (1990) Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxix, and intradermal inflammatory reactions. J. Exp. Med. 171, 913-927.
14. Perretti, M., Becherucci, C., Mugridge, K.G., Solito, E., Silvestri, S., and Parente, L. (1991) A novel antiinflammatory peptide from human lipocortin 5. Br. J. Pharmacol. 103, 1327-1332.
15. Moreno, J.J. (1997) Antiflammins: endogenous nonapeptide with regulatory effect on inflammation. Gen. Pharmacol. 28, 23-26.
16. Weng, X., Luecke, H., Song, I.S., Kang, D.S., Kim, S.-H., and Huber, R. (1993) Crystal structure of human annexin I at 2.5å resolution. Prot. Sci. 2, 448-458.
17. Le, Y., Murphy, P.M., and Wang, J.M. (2002) Formyl-peptide receptors revisited. Trends Immunol. 23, 541-548.
18. Moreno, J.J. (2001) Antiflammin-2 prevents HL-60 adhesion to endothelial cells and prostanoid production induced by lipopolysaccharides. J. Pharmacol. Exp. Ther. 296, 884-889.
19. Bae, Y.S., Yi, H.J., Lee, H.Y., Jo, E.J., Kim, J.I., Lee, T.G., Ye, R.D., Kwak, J.Y., and Ryu, S.H. (2003) Differential activation of formyl peptide receptor-like 1 by peptide ligands. J. Immunol. 171, 6807-6813.
20. Perretti, M., Chiang, N., La, M., Fierro, I.M., Marullo, S., Getting, S.J., Solito, E., and Serhan, C.N. (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 8, 1296-1302.
21. Hayhoe, R.P., Kamal, A.M., Solito, E., Flower, R.J., Cooper, D., and Perretti, M. (2006) Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 107, 2123-2130.
22. Perretti, M., Croxtall, J.D., Wheller, S.K., Goulding, N.J., Hannon, R., and Flower, R.J. (1996) Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat. Med. 22, 1259-1262.
23. Patel, K.D. (1999) Mechanisms of selective leukocyte recruitment from whole blood on cytokine-activated endothelial cells under flow conditions. J. Immunol. 162, 6209-6216.
24. Nanamori, M., Cheng, X., Mei, J., Sang, H., Xuan, Y., Zhou, C., Wang, M.W., and Ye, R.D. (2004) A novel nonpeptide ligand for formyl peptide receptor-like 1. Mol. Pharmacol. 66, 1213-1222.
25. Walther, A., Riehemann, K., and Gerke, V. (2000) A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell 5, 831-840.
26. 2+ to annexin I. J. Mol. Biol. 306, 825-835.
27. Rosengarth, A. and Luecke, H. (2003) A calcium-driven conformational switch of the N-terminal and core domains of annexin A1. J. Mol. Biol. 326, 1317-1325.
28. 2+-dependent phospholipid binding and phosphorylation of lipocortin I. J. Biol. Chem. 262, 6931-6937.
29. Takano, T., Fiore, S., Maddox, J.F., Brady, H.R., Petasis, N.A., and Serhan, C.N. (1997) Aspirin-triggered 15-epilipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 185, 1693-1704.
30. Su, S.B., Gong, W., Gao, J.L., Shen, W., Murphy, P.M., Oppenheim, J.J., and Wang, J.M. (1999) A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189, 395-402.
31. Harada, M., Habata, Y., Hosoya, M., Nishi, K., Fujii, R., Kobayashi, M., and Hinuma, S. (2004) N-Formylated humanin activates both formyl peptide receptor-like 1 and 2. Biochem. Biophys. Res. Commun. 324, 255-261.
32. 4 receptor. Blood 95, 1810-1818.
33. Christophe, T., Karlsson, A., Dugave, C., Rabiet, M.J., Boulay, F., and Dahlgren, C. (2001) The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J. Biol. Chem. 276, 21585-21593.
34. Alldridge, L.C., Harris, H.J., Plevin, R., Hannon, R., and Bryant, C.E. (1999) The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. J. Biol. Chem. 274, 37620-37628.
35. Alldridge, L.C. and Bryant, C.E. (2003) Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp. Cell Res. 290, 93-107.
36. He, R., Tan, L., Browning, D.D., Wang, J.M., and Ye, R.D. (2000) The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor. J. Immunol. 165, 4598-4605.
37. Bae, Y.S., Park, J.C., He, R., Ye, R.D., Kwak, J.Y., Suh, P.G., and Ryu, S.H. (2003) Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. Mol. Pharmacol. 64, 721-730.
38. Karlsson, J., Fu, H., Boulay, F., Dahlgren, C., Hellstrand, K., and Movitz, C. (2005) Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors. J. Leukoc. Biol. 78, 762-771.
39. Perretti, M. (1994) Lipocortin-derived peptides. Biochem. Pharmacol. 47, 931-938.